PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 171 filers reported holding PRECIGEN INC in Q4 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18 | +28.6% | 12,389 | +1.7% | 0.00% | – |
| Q2 2023 | $14 | 0.0% | 12,184 | -7.9% | 0.00% | – |
| Q1 2023 | $14 | -6.7% | 13,223 | +33.6% | 0.00% | – |
| Q4 2022 | $15 | -99.9% | 9,897 | +8.1% | 0.00% | – |
| Q3 2022 | $20,000 | +81.8% | 9,156 | +13.2% | 0.00% | – |
| Q2 2022 | $11,000 | -26.7% | 8,088 | +16.2% | 0.00% | – |
| Q1 2022 | $15,000 | -31.8% | 6,959 | +16.1% | 0.00% | – |
| Q4 2021 | $22,000 | -15.4% | 5,992 | +18.0% | 0.00% | – |
| Q3 2021 | $26,000 | -21.2% | 5,077 | 0.0% | 0.00% | – |
| Q2 2021 | $33,000 | -5.7% | 5,077 | 0.0% | 0.00% | – |
| Q1 2021 | $35,000 | -32.7% | 5,077 | 0.0% | 0.00% | – |
| Q4 2020 | $52,000 | +188.9% | 5,077 | 0.0% | 0.00% | – |
| Q3 2020 | $18,000 | -28.0% | 5,077 | 0.0% | 0.00% | – |
| Q2 2020 | $25,000 | – | 5,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |